Top

Published in:

01-05-2016 | Clinical study

Lowest risks with ethinylestradiol/levonorgestrel oral contraception

Published in: Reactions Weekly | Issue 1/2016

Excerpt

Use of a levonorgestrel-containing oral contraceptive approximately halved the risk of pulmonary embolism compared with products containing a third-generation progestogen, according to the results of an observational cohort study published in the BMJ. In addition, the risk of pulmonary embolism, myocardial infarction or stroke was decreased in products using 20µg rather than 30−40µg of ethinylestradiol. …

Weill A, et al. Low dose oestrogen combined oral contraception and risk of pulmonary embolism, stroke, and myocardial infarction in five million French women: Cohort study. BMJ 353: i2002, 10 May 2016. Available from: URL: http://dx.doi.org/10.1136/bmj.i2002

Title: Lowest risks with ethinylestradiol/levonorgestrel oral contraception
Publication date: 01-05-2016
Publisher: Springer International Publishing
Published in: Reactions Weekly / Issue 1/2016
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-016-17551-2

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Lowest risks with ethinylestradiol/levonorgestrel oral contraception

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2016

Immunosuppressants

Antineoplastics

Pentazocine abuse/withdrawal

Nitrofurantoin

Multiple drugs

Topiramate/valproic acid interaction